Form 8-K - Current report:
SEC Accession No. 0001193125-25-075911
Filing Date
2025-04-09
Accepted
2025-04-08 17:35:17
Documents
15
Period of Report
2025-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d907211d8k.htm   iXBRL 8-K 61105
2 EX-4.1 d907211dex41.htm EX-4.1 1012453
3 EX-10.1 d907211dex101.htm EX-10.1 1484456
  Complete submission text file 0001193125-25-075911.txt   3287534

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bhc-20250408.xsd EX-101.SCH 2519
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20250408_lab.xml EX-101.LAB 17911
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20250408_pre.xml EX-101.PRE 11229
18 EXTRACTED XBRL INSTANCE DOCUMENT d907211d8k_htm.xml XML 3751
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 25823100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)